PipelineReview.com - All Products

Show Cart

All Products

Results 1 - 20 of 189

Jun 2021 Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

May 2020 Report Package: “Drug the Undruggable” Technologies

(Discount: 50.00%)

May 2020 Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Apr 2020 STING Agonists & Antagonists – Target Pipeline List 04/2020

Mar 2020 Blockbuster Biologics 2019: Sales of Recombinant Therapeutic Antibodies & Proteins

Feb 2020 TIGIT-Targeted Immunotherapeutics – Target Pipeline List 02/2020

Feb 2020 Sales Database for Therapeutic Antibodies & Proteins: 1-Year Subscription

Dec 2019 Competitor Analysis: Next Wave Biosimilar Antibodies of Lucentis, Eylea, Xolair, Prolia, Stelara, Soliris and More

Oct 2019 Flat-Rate Subscription to La Merie Publishing Reports

Oct 2019 Competitor Analysis: KRAS Inhibitors

Sep 2019 Competitor Analysis: TGF-beta/Receptor Inhibitors

Sep 2019 Competitor Analysis: RORgamma Antagonists and Agonists

Sep 2019 RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Jul 2019 CD137 Costimulatory Receptor Agonists – Target Pipeline List 07/2019

Jun 2019 CD38-Targeted Antibody & Cell Therapy – Target Pipeline List 06/2019

Jun 2019 Report Package: Bispecific Antibodies

(Discount: 20.00%)

Jun 2019 Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

Jun 2019 T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

May 2019 CD33-Targeted Antibody & Cell Therapy – Target Pipeline List 05/2019

Apr 2019 CD40 Agonists – Target Pipeline List 04/2019

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End

Shopping cart

Cart empty

Latest report

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Featured Products

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Latest Target Pipeline

STING Agonists & Antagonists

Shopping cart

Cart empty

Latest report

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Featured Products

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Latest Target Pipeline

STING Agonists & Antagonists

La Merie Biologics

FREE Weekly News Bulletin

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing